Signo de Chilaiditi

Márquez, Bernat de Pablo; Lopez, David; Font, David García; Diestro, Jovita Roda; Vargas, Silvia Romero

doi:10.1016/j.gastrohep.2015.12.002

Cited by 3 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Interestingly, NPPV resulting in aerophagia did not differ signi cantly between groups, despite being a known risk factor for CS 10 . In terms of bowel dilation as a bowel factor for CS, NPPV was estimated to more easily result in development of CS compared to TPPV, because of the continuous entry of air into the stomach 21 .…”

Section: Discussionmentioning

confidence: 76%

“…The sign is often not associated with symptoms, but is potentially important due to associations with clinically recurrent abdominal pain or even colonic volvulus, following compression of the gastric outlet by the abnormally placed colon in CS 9 . The cause of CS has been considered to involve morphological abnormality of the right diaphragm, liver, and intestine, such as diaphragmatic weakness, liver cirrhosis, and abnormal gas accumulation due to aerophagia 10 .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Diagnostic Yield of Chilaiditi’s Sign in Advanced-Phase Late-Onset Pompe Disease

Takahashi

Mori‐Yoshimura

Ariga

et al. 2021

Preprint

View full text Add to dashboard Cite

Purpose: Chilaiditi’s sign (CS), hepatodiaphragmatic interposition of the intestine, was caused by morphological abnormalities such as diaphragmatic atrophy, intestinal dilation, and liver atrophy. The sign is potentially important due to associations with clinically recurrent abdominal pain or even colonic volvulus. In general, neuromuscular disease (NMD) could have the high prevalence of CS because of widened hepatodiaphragmatic space, following diaphragmatic atrophy. Particularly, in late-onset Pompe disease (LOPD), glycogen accumulation in smooth muscle of intestine could lead to the abnormal dilation of intestine. Though the prevalence of CS in LOPD could be high because of developing two main factors of CS, no studies have evaluated the prevalence of CS in LOPD. Our aim was to investigate the prevalence of CS in LOPD, and to identify the risk factors of CS in LOPD patients. Methods: Medical records of genetically confirmed patients of Pompe disease at the National Center Hospital, National Center of Neurology and Psychiatry were retrospectively reviewed. We evaluated CS using chest X-ray (CXR) and abdominal CT and assessed the prevalence of CS in LOPD patients. We also divided the patients into two groups, CS and non-CS group, and evaluated the factor associated with CS compared to clinical variables between groups. Results: Three of seven (43%) were detected in CS. CS group (P5-7) and non-CS group (P1-4) were obtained. In comparison of clinical variables, the severity of atrophy in right diaphragms was significantly higher in CS than non-CS groups (p =0.029). Also, the frequency of abnormal position of right diaphragm and liver, and abnormally dilated bowel was seen in all of CS patients, but none of non-CS patient (p = 0.029, each). Conclusion: In LOPD patients, the prevalence of CS was much higher of 43%, compared to healthy groups, or even in similarly respiratory muscle impaired neuromuscular diseases such as Duchenne muscular dystrophy (DMD) or Myotonic dystrophy type 1 (DM1). The anatomically abnormal position of diaphragm and liver, atrophy and fat infiltration of diaphragms, and abnormally dilated bowel were significantly associated with CS in LOPD. Since CS can cause intestinal symptoms or even contribute to sudden-death of intestinal volvulus, we should pay more attention to CXR or abdominal CT as follow up in LOPD patients.

show abstract

Section: Discussionmentioning

confidence: 76%

Section: Introductionmentioning

confidence: 99%

Diagnostic Yield of Chilaiditi’s Sign in Advanced-Phase Late-Onset Pompe Disease

Takahashi

Mori‐Yoshimura

Ariga

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…Particularmente, esta paciente presentaba el "síndrome de Chilaiditi", una alteración anatómica en la que una parte del colon se interpone entre el hígado y el diafragma (4,5). Teniendo en cuenta este fenómeno anatómico y debido a que la aparición de la orina lactescente fue posterior a la colocación de la PEG y cesó cuando esta se retiró, se pensó que pudo haber sido una inadecuada colocación de la PEG la que causó la aparición de la nutrición enteral en la muestra de orina.…”

unclassified

Diagnosis: chyluria

Mora¹,

Chacón²,

Zamorano³

2021

Rev Med Lab

View full text Add to dashboard Cite

Chilaiditi Syndrome: A Rare Case and Clinical Insights for Diagnosis and Management

Silva,

Moutinho,

Vasconcelos

et al. 2023

Cureus

View full text Add to dashboard Cite

Chilaiditi syndrome is a rare medical condition characterized by the interposition of a hollow organ, usually the colon, between the liver and diaphragm, leading to abdominal pain, discomfort, bloating, constipation, or nausea; in more severe instances, respiratory symptoms may manifest due to pressure on the diaphragm. The exact cause remains unclear but is thought to present along with various factors such as anatomical anomalies (hepato-diaphragmatic interposition and intestinal malrotation) and chronic conditions (cirrhosis or chronic obstructive pulmonary disease). This case report presents a 78-year-old male with rapid deterioration, confusion, and mild abdominal discomfort. Clinical and radiological examinations confirmed Chilaiditi syndrome, highlighting the challenges in diagnosis. Management strategies range from conservative approaches to surgical interventions, emphasizing the need for increased clinical awareness among physicians to ensure accurate and timely interventions. This case report underscores the importance of recognizing this rare condition.

show abstract

Signo de Chilaiditi

Cited by 3 publications

References 5 publications

Diagnostic Yield of Chilaiditi’s Sign in Advanced-Phase Late-Onset Pompe Disease

Diagnostic Yield of Chilaiditi’s Sign in Advanced-Phase Late-Onset Pompe Disease

Diagnosis: chyluria

Chilaiditi Syndrome: A Rare Case and Clinical Insights for Diagnosis and Management

Contact Info

Product

Resources

About